Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Leukemia. 2020 Jul 12;34(12):3404–3407. doi: 10.1038/s41375-020-0974-y

Figure 1. Kaplan-Meier Curve of First Onset of Grade 3 or Higher Transaminase Elevation Among 853 Patients Treated with Idelalisib, by Significant Risk Factor.

Figure 1.

Figure 1.

Figure 1.

A. Previously untreated (31.7%) vs previously treated (17.6%) (p<=0.0001). B-C. By age, in ten year increments. B. Entire dataset (p=0.01). C. Relapsed refractory patients, N=490 (p=0.001).